Fauvel, C., Liu, Z., Lin, S., Correa-Jaque, P., Webb, A., Vanderpool, R., Kanwar, M., Kraisangka, J., Mathur, P., Perer, A., Everett, A., & Benza, R. L. “Comparison between PAH risk assessment methods including PHORA”. BACKGROUND. Risk assessment is critical to predict survival and then guide therapeutic management for pulmonary arterial hypertension (PAH) patients. Several risk […]
Liu, Z., Fauvel, C., Lin, S., Correa-Jaque, P., Webb, A., Vanderpool, R., Kanwar, M., Kraisangka, J., Mathur, P., Perer, A., Everett, A., & Benza, R. L. “Pulmonary Arterial Hypertension Risk Assessment model using Random Forrest and Bayesian Network”. Background and rationale: Existing risk assessment models in pulmonary arterial hypertension (PAH) are powerful in predicating survival. […]
Fauvel, C., Webb, A., Liu, Z., Lin, S., Correa-Jaque, P., & Benza, R. L. “Pulmonary Arterial Hypertension risk assessment genomic model using Bayesian Network”. BACKGROUND AND RATIONALE. Accurate risk assessment is essential to making individualized treatment decision in pulmonary arterial hypertension (PAH) patients. Yet, existing probabilistic risk assessment models are insufficient since they did not […]
Liu, Z., An, H.,Lin, S., Kraisangka, J., Correa-Jaque, P., Webb, A., Tiwari, H., Wiener, H., Benza, R. “Clinical Variables in Predicting Survival and Hospitalization for Pulmonary Arterial Hypertension Using Harmonized Data.” The Journal of Heart and Lung Transplantation, vol. 41, no. 4, Apr. 2022, pp. S34–35. Purpose: Pulmonary arterial hypertension (PAH) is a type of […]
Webb, A., An, H., Correa-Jaque, P., Lin, S., Liu, Z., Tiwari, H. K., Wiener, H., & Benza, R. L. “Abstract 11344: Association of Canonical Pathways with Length of Survival in Pulmonary Arterial Hypertension.” Circulation, vol. 144, no. Suppl_1, Nov. 2021, pp. A11344–A11344. Introduction: Pulmonary arterial hypertension (PAH) is a chronic, progressive disease without cure. Treatment can improve […]
Kraisangka, J., Scott, J., Kanwar, M., Liu, Z., Lin, S., Everett, A., Perer, A., Movahedi, F., Antaki, J., & Benza, R. “LAB parameters in predicting survival in Pulmonary arterial hypertension”. Chest, vol. 160, no. 4, Oct. 2021, p. A2335. PURPOSE: Lab values are essential sets of parameters for the prognosis of the patients with pulmonary arterial […]
Kraisangka, J., Scott, J., Kanwar, M., Liu, Z., Lin, S., Everett, A., Perer, A., Movahedi, F., Antaki, J., Benza, R. “EKG Parameters In Predicting Survivals In Pulmonary Arterial Hypertension.” Chest, vol. 160, no. 4, Oct. 2021, pp. A2325–26. PURPOSE: EKG parameters are ones of the predictors for prognosis of the patients with pulmonary arterial hypertension (PAH). […]
Benza, R., Kanwar, M., Antaki, J., Dhabalia, A., Manavalan, M., Xin, Z., Perer, A. “Effective Communication of Machine Learning Models In Clinical Decision Support Tools For PAH Risk Prediction”. Chest, vol. 160, no. 4, Oct. 2021, pp. A1396–97. PURPOSE: Risk-stratification in pulmonary artery hypertension (PAH) is essential to determine prognosis, monitor disease progression, and response […]
Kanwar, M. K., Krainsangka, J., Scott, J., Perer, A., Antaki, J., Benza, R. “Hemodynamic Parameters in Predicting Time to Clinical Worsening in Pulmonary Arterial Hypertension.” The Journal of Heart and Lung Transplantation, vol. 40, no. 4, Apr. 2021, p. S189. PurposeHemodynamics are considered to be extremely relevant when clinically assessing patients with PAH, especially for […]
Kanwar, M. K., Krainsangka, J., Scott, J., Barrett, T., Everett, A., Perer, A., Antaki, J., Benza, R. “Hemodynamic Parameters in Predicting Survival in Pulmonary Arterial Hypertension.” The Journal of Heart and Lung Transplantation, vol. 40, no. 4, Supplement, Apr. 2021, p. S188. PurposeHemodynamics are considered to be extremely relevant when clinically assessing patients with pulmonary arterial […]
